Clinical Trials on Hypotension in Germany

Total 641 results

University of Giessen
Edwards Lifesciences

Completed

The "Hypotension Prediction Index" in Patients Undergoing Lung Surgery

Myocardial Injury | Renal Failure | Hypotension | Anesthesia | Hemodynamic Instability

Germany
Implandata Ophthalmic Products GmbH

Completed

Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)

Primary Open-angle Glaucoma

Germany
RWTH Aachen University
Fasciotens GmbH

Recruiting

Fasciotens to Treat an Open Abdomen - a Prospective Cohort Study (Fasciotens)

Peritonitis | Pancreatitis,Acute Necrotizing | Abdominal Compartment Syndrome | Intraabdominal Hypertension

Germany
Bayer

Active, not recruiting

Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)

Hypertension, Pulmonary

Germany
Carl Zeiss Meditec AG

Active, not recruiting

Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT)

Primary Open-angle Glaucoma

Germany
Technische Universität Dresden

Recruiting

Dresden Glaucoma and Treatment Study (DGTS)

Glaucoma | Glaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Low Tension

Germany
Abbott Medical Devices

Completed

EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension

Uncontrolled Hypertension

Germany
Sight Sciences, Inc.

Terminated

Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)

Glaucoma, Open-Angle

Germany, Spain, United Kingdom
University of Erlangen-Nürnberg Medical School

Completed

Renal Nerve Ablation in Chronic Kidney Disease Patients

Hypertension | Chronic Kidney Disease

Germany
Novartis Pharmaceuticals

Completed

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Pulmonary Arterial Hypertension

Germany, Belgium, United States, Lithuania, United Kingdom, Italy, Australia
Technical University of Munich

Completed

Impact of Sympathetic Renal Denervation- a Study in Patients After Renal Transplantation (ISAR-denerve)

Hypertension | Chronic Kidney Disease | Renal Transplantation | Sympathetic Activity

Germany
Abbott Medical Devices

Completed

A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence (RDN+AF)

Hypertension | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation

Germany
Novartis Pharmaceuticals

Recruiting

Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants

Pulmonary Arterial Hypertension

Spain, Germany, Netherlands, Poland, United Kingdom, Argentina, United States
Boehringer Ingelheim

Terminated

SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients

Hypertension | Coronary Arteriosclerosis

Germany
Novartis

Completed

A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients

Hypertension

United States, Germany
Novartis

Completed

Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension

Hypertension

United States, Germany
Novartis Pharmaceuticals

Completed

Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects

Hypertension | Concurrent Obesity

Germany, Netherlands
Lung Biotechnology PBC

Completed

Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States, Belgium, Czechia, Germany, Ireland, Romania
Oertli Instrumente AG
University of Geneva, Switzerland

Unknown

High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP (HFDS_abinterno)

Glaucoma | Cataract | POAG

Germany, Switzerland, Egypt, India
Novartis

Completed

VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

Hypertension

Switzerland, Germany
Lung Biotechnology PBC

Completed

Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients

Pulmonary Arterial Hypertension

United States, Belgium, Czechia, Germany, Ireland, Romania
Technische Universität Dresden

Completed

The Effect of Selective Laser Trabeculoplasty (SLT) on Ocular Rigidity (SLT/ORA)

Glaucoma

Germany
Ludwig-Maximilians - University of Munich
Bayer

Completed

Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients (METATEL)

Hypertension | Metabolic Syndrome | Hypertriglyceridemia

Germany
Novartis Pharmaceuticals

Terminated

Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

Switzerland, United States, Germany, Singapore, Korea, Republic of, Canada
University of Erlangen-Nürnberg Medical School

Completed

Accuracy of 1.5 T Versus 3 T Magnetic Resonance Arterial Spin Labeling to Measure Renal Blood Flow

Hypertension | Chronic Kidney Disease

Germany
University Hospital Tuebingen
Alcon Research

Unknown

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients (TRASCO)

Primary Open Angle Glaucoma (POAG)

Germany
University of Erlangen-Nürnberg Medical School

Completed

Effect of Pioglitazone on Ambulatory Blood Pressure

Hypertension | Diabetes Mellitus Type 2

Germany
Boehringer Ingelheim

Completed

Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism

Hypertension | Coronary Arteriosclerosis

Germany
Institut für Pharmakologie und Präventive Medizin

Completed

Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg (Sevicontrol-2)

Hypertension

Germany
Universität Duisburg-Essen
Charite University, Berlin, Germany; University of Witten/Herdecke; Kliniken... and other collaborators

Completed

Comprehensive Lifestyle Modification for Patients With Hypertension and Metabolic Syndrome: a Multicenter Randomized Controlled Trial

Hypertension | Metabolic Syndrome

Germany
Theravance Biopharma

Terminated

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (OAK)

Symptomatic Neurogenic Orthostatic Hypotension

United States, Spain, Portugal, United Kingdom, France, Denmark, Ukraine, Israel, Estonia, Poland, Italy, Russian Federation, Australia, Austria, Bulgaria, Canada, Germany, New Zealand
University of Erlangen-Nürnberg Medical School

Withdrawn

Sympathetic Nerve Activity in Renal Failure (SNS in CRF)

Hypertension | Chronic Kidney Disease

Germany
Novartis Pharmaceuticals

Completed

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

Hypertension

Czech Republic, Finland, France, Germany, Hungary, Italy, Poland, Slovakia, Spain, Sweden
University of Erlangen-Nürnberg Medical School

Recruiting

Renal Denervation in ADPKD- RDN-ADPKD Study (RDN-ADPKD)

Autosomal Dominant Polycystic Kidney Disease | Uncontrolled Hypertension | Renal Denervation

Germany
Novartis

Terminated

Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension

Hypertension | Abdominal Obesity

Germany
Charite University, Berlin, Germany

Recruiting

Berlin-Brandenburg Pregnancy Cohort (BBPC)

Pregnancy Complications | Preeclampsia | Diabetes Mellitus in Pregnancy

Germany
Stanford University
NYU Langone Health; Wills Eye; Otto-von-Guericke University Magdeburg

Recruiting

Electrical Stimulation for the Treatment of Glaucoma (rtACS)

Glaucoma | Glaucoma, Open-Angle

United States, Germany
Novartis Pharmaceuticals

Active, not recruiting

Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

United States, Spain, Germany, Poland, United Kingdom, Netherlands, Argentina
Ablative Solutions, Inc.

Completed

The Peregrine Post-Market Study for the Treatment of Hypertension

Hypertension

Belgium, Czechia, Germany, Poland
University of Erlangen-Nürnberg Medical School

Active, not recruiting

Renal Denervation in Chronic Kidney Disease - RDN-CKD Study (RDN-CKD)

Chronic Kidney Disease stage3 | Uncontrolled Hypertension | Renal Denervation

Germany
Nova Eye, Inc.
Nova Eye Medical GmbH

Recruiting

Multicenter Glaucoma Study Investigating Standalone Canaloplasty (MAGIC)

Primary Open Angle Glaucoma

United Kingdom, Germany, Spain
University Hospital Schleswig-Holstein

Completed

Intravenous Beta-blockade for Improvement of Autonomic Activity

Hypertension | Tachycardia | Heart Rate Variability

Germany
Abbott
Quintiles, Inc.; Synexus; author! et al. BV

Completed

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Essential Hypertension

Germany, Russian Federation, United Kingdom
iSTAR Medical

Recruiting

MINIject Global Long-Term Follow-up Study (STAR-GLOBAL)

Ocular Hypertension | Open Angle Glaucoma

Germany, Spain, Colombia, France, India, Panama
University of Erlangen-Nürnberg

Unknown

Contrast Sensitivity in Glaucoma

Primary Open Angle Glaucoma | Secondary Open Angle Glaucoma Due to PEX

Germany
Medtronic Vascular

Completed

Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2) (HTN-2)

Uncontrolled Hypertension

Spain, Australia, Germany, France, Latvia, United Kingdom, Belgium, Austria, Poland, Switzerland
Novartis Pharmaceuticals

Completed

Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients

Patients, Resistant Hypertension

Germany, Switzerland, United States, France, Netherlands, Denmark
Novartis

Completed

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone

Hypertension

Sweden, Slovakia, Argentina, Germany, Turkey, Norway, Poland
Novartis

Completed

A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg

Hypertension

United States, Germany
Universitätsklinikum Hamburg-Eppendorf
German Federal Ministry of Education and Research

Completed

Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback (DEPSCREEN-INFO)

Hypertension | Depressive Episode | Chronic Ischaemic Heart Disease

Germany

Clinical Trials on Hypotension in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations